Commentary: Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies.

Berger, Joseph R; Hartung, Hans-Peter.

Afiliação

Berger JR; Department of Neurology, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, United States.
Hartung HP; Department of Neurology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.

Front Neurol ; 14: 1146027, 2023.

Article em En | MEDLINE | ID: mdl-37006492

Palavras-chave

immunogenetics; multiple sclerosis; natalizumab; progressive multifocal leucoencephalopathy (PML); risk factors

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article